New York, Aug 26: Biotechnology major Moderna on Friday sued rival Pfizer and BioNTech over alleged infringement of its messenger RNA (mRNA) vaccine technology patents.
In the lawsuit filed in the US and Germany, Moderna alleged that Pfizer and BioNTech’s Covid-19 vaccine ‘Comirnaty’ unlawfully infringes patents Moderna filed between 2010 and 2016 for its foundational mRNA technology, critical to the development of Moderna’s own mRNA vaccine, ‘Spikevax’.
“We are filing these lawsuits to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the COVID-19 pandemic,” said Moderna CEO Stephane Bancel.
The company said that Pfizer and BioNTech copied this technology, without Moderna’s permission, to make Comirnaty.
In October 2020, Moderna pledged not to enforce its Covid-19 related patents while the pandemic continued.
In March 2022, when the collective fight against Covid-19 entered a new phase and vaccine supply was no longer a barrier to access in many parts of the world, Moderna updated its pledge.
It made clear that while it would never enforce its patents for any Covid vaccine used in the 92 low- and middle-income countries, Moderna expected companies such as Pfizer and BioNTech to respect its intellectual property rights and would consider a commercially reasonable license should they request one for other markets. Pfizer and BioNTech have failed to do so.
“We believe that Pfizer and BioNTech unlawfully copied Moderna’s inventions, and they have continued to use them without permission,” said Moderna Chief Legal Officer Shannon Thyme Klinger.
“Outside of 92 countries, where vaccine supply is no longer a barrier to access, Moderna expects Pfizer and BioNTech to compensate Moderna for Comirnaty’s ongoing use of Moderna’s patented technologies,” Klinger added.
Moderna said it is not seeking to remove Comirnaty from the market and is not asking for an injunction to prevent its future sale.
In addition, Moderna said it is not seeking damages related to Pfizer’s sales to 92 countries and is not seeking damages for Pfizer’s sales where the US government would be responsible for any damages
Moderna believes Pfizer and BioNTech copied two key features of Moderna’s patented technologies which are critical to the success of mRNA vaccines.
“When Covid-19 emerged, neither Pfizer nor BioNTech had Moderna’s level of experience with developing mRNA vaccines for infectious diseases, and they knowingly followed Moderna’s lead in developing their own vaccine,” said the company.
Pfizer/BioNTech have also been sued for patent infringement by CureVac.
Moderna is also facing lawsuits from biotechnology companies Arbutus Biopharma and Genevant Sciences.
Another biotechnology company, Alnylam, is suing both Pfizer/BioNTech and Moderna over a similar technology.
–IANS
Indian-origin researcher unravels link between depression and heart disease
New Delhi: Depression and cardiovascular disease (CVD) partly develop from the same gene module, said a team of researchers establishing the long-presumed link between the two conditions. Since the 1990s,...
Kejriwal administered insulin in Tihar: AAP
New Delhi: Incarcerated Delhi Chief Minister Arvind Kejriwal was given insulin in Tihar jail for the first time after ED arrest, AAP sources said on Tuesday. “Kejriwal's sugar level was...
From breast cancer to brain, DNA damage – here’s how ethylene oxide can affect your health
New Delhi: Ethylene oxide is a cancer-causing agent that can raise the risk of breast cancer, as well as cause damage to the DNA, the brain, and the nervous system...
New immunotherapy to fight cancer, keep healthy cells safe
New Delhi: A team of US researchers has developed a new immunotherapy technique that uses cytokine proteins as a potential treatment, effectively targeting tumours without causing harm to healthy cells....
Nestle adds sugar to baby food sold in India but not in Europe
New Delhi: The baby-food brands sold by global giant Nestle in India contain high levels of added sugar, while such products are sugar-free in the United Kingdom, Germany Switzerland, and...
Why India is seeing a rise in oral cancer cases
New Delhi: India bears a significant burden of oral cancers, and the country contributes to about 30 per cent of all global cases, said doctors on Tuesday. April is Oral...
Why India is seeing a rising trend of diseases
New Delhi: Increased stress in life and a sedentary lifestyle combined with a spike in consumption of junk food, smoking tobacco, and alcohol is behind the surging cases of diseases...
This vaccine helped over 50 pc of people remain UTI-free for years
New Delhi: More than 50 per cent of people remained Urinary Tract Infection (UTI)-free for up to nine years who received the oral spray-based vaccine 'MV140', a new study has...
Tingling, burning, numbness in your feet? It can be a sign of prediabetes
New Delhi: If you are regularly experiencing tingling, burning, numbness, and pain in your feet, you may be prediabetic -- a sign that your body’s insulin levels are rising, said...
President Droupadi Murmu unveils 1st ‘India-made’ affordable gene therapy for cancer
New Delhi: In a ray of hope for millions suffering from cancer, President Droupadi Murmu on Thursday unveiled the country’s first indigenously-made and affordable gene therapy for the deadly disease....
Centre calls media reports on hike in medicine prices ‘false & misleading’
New Delhi: The Union Ministry of Health and Family Welfare on Wednesday said that media reports claiming a significant hike in medicine prices are “false, misleading and malicious”. Some media...
Mumbai doctors save micro-preemie baby born at 23 weeks weighing 620 grams
Mumbai: In a rare case, doctors here have given a new lease of life to a micro-preemie baby girl born at 23 weeks, weighing just 620 grams. Micro-preemies are babies...
